Position in ADCT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$984,731
+$983,035 QoQ
Shares Held
262,595
+21728.3% QoQ
Ownership
0.206%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADCT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026LAZARD ASSET MANAGEMENT LLC holds $165,612,539 across 22 Drug Manufacturers - Specialty & Generic names. ADCT ranks #11 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
912,970 | $107,922,182 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
124,479 | $16,398,863 | |
| 3 | RDY |
Dr Reddys Laboratories Ltd
|
1,059,831 | $14,678,659 | |
| 4 | PAHC |
Phibro Animal Health Corp
|
145,811 | $8,064,806 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
10,232 | $6,067,371 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
90,154 | $2,157,385 | |
| 7 | CGC |
Canopy Growth Corp
|
1,807,986 | $1,715,778 | |
| 8 | ESPR |
Esperion Therapeutics, Inc.
|
580,705 | $1,591,131 |
All Filings in ADCT
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $984,731 | 262,595 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $1,696 | 1,203 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $11,577 | 5,818 | Shares | Sole | 2025-02-14 | |
| 2022-06-30 | $127,979 | 16,098 | Shares | Sole | 2022-08-09 | |
| 2021-12-31 | $37,632 | 1,863 | Shares | Sole | 2022-02-09 | |
| No filing history on record for this holder in this stock. | ||||||